Delivery Order SPE2DR25D2206-SPE2DR26F9SU4

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Visipaque 320 mg/ml (100 ml bottles) with a ceiling value of $10,399.20 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion by February 11, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 25, 2026, for Visipaque 320 mg/ml infusion bottles (150 ml) with a ceiling value of $1,018.00.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 26, 2026. The order is priced on a firm fixed-price basis with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $1,864.00 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Visipaque 320 mg/ml infusion bottles (150 ml), with an ultimate completion date of February 13, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued under firm fixed-price terms with no set-aside.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Visipaque 320 mg/ml in 100 ml bottles, with a ceiling value of $3,379.74. Place of performance is Conshohocken, PA. Ultimate completion date is February 25, 2026. The order was issued under firm fixed-price terms with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense...

The Defense Logistics Agency (DLA) awarded a $2,859.78 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 16, 2026, for the procurement of Visipaque 320 mg/ml in 100ml bottles. This non-set-aside contract is scheduled for completion by January 20, 2026, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Visipaque is a contrast medium used in radiological and cardiovascular imaging procedures, representing a critical medical...

The Defense Logistics Agency awarded a $3,379.74 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Visipaque 320 mg/ml in 100ml bottles, with completion scheduled for January 5, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Visipaque is a contrast agent used in medical imaging procedures, representing part of the broader...

The Defense Logistics Agency awarded a $7,589.05 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Visipaque 320 mg/ml infusion bottles (150ml). This is a firm fixed-price contract with an ultimate completion date of January 23, 2026, and represents a non-set-aside award issued under competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,299.90 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed-price contract was issued on January 13, 2026, with a completion date of January 14, 2026, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...

The Defense Logistics Agency awarded a delivery order valued at $2,079.84 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in a 100 ml bottle on January 23, 2026. This firm fixed-price delivery order, with completion scheduled for January 26, 2026, represents a small-value pharmaceutical procurement issued under a larger indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through open...